<DOC>
	<DOCNO>NCT02591004</DOCNO>
	<brief_summary>The aim study investigate possible use calcium channel neuroprotectant case PTL . This do comparing effect cerebral blood vessel already establish MgSo4 . They prove superior magnesium sulphate tocolysis , posse mechanism action would allow theoretical use neuroprotective agent .</brief_summary>
	<brief_title>Calcium Channel Blockers Compared Magnesium Sulfate Fetal Cerebral Blood Flow</brief_title>
	<detailed_description>After internal review board approval obstetrics gynecology department Kasr Alainy hospital , 130 patient recruit randomized case control study . The patient recruit emergency admission department , fulfil recruitment criterion . In independent case-control study Sample size calculate use odds ratio exposure CP 0.14 ( 95 % CI 0.05-0.51 ) ( Grether et.al , 1998 ) , alpha level error fix 0.5 power set 80 % , optimal sample size calculate 65 patient arm . Patients randomized admission nurse labor ward either one two group . Group A receive MgSo4 , group B receive Nifedipine ( Epilat 20mg ® EIPICO Egypt ) . Randomization achieve computer generate randomization table . Recruitment continue till 65 patient allocate group . Patients group A receive 4 gm intravenous ( I.V ) MgSo4 load dose 30 min &amp; 1 gm/ hour maintenance dose 24 hour , till labor occurs ( whichever occurs first ) , give accordance Australian Research Centre Health Women Babies , 2010 , use MgSo4 neuroprotection CP . While patient group B receive Nifedipine ( Epilat 10mg ® EIPICO Egypt ) , recommend dose use nifedipine neuroprotectant , dose give study use tocolysis . Nifedipine wil give load dose 40 mg 1st hour ( 10mg give every 15 min ) , maintenance dose 60mg /24 hour , divide 3 dos ( Hösli et.al , 2014 ) . The ability MgSo4 neuro protectant dependent cerebral vasodilating effect ( Magee et.al,2011 ; Macdonald et.al , 2004 ) , therefore propose measure mean pulsility index ( PI ) resistance index ( PI ) middle cerebral artery fetus twice , give drug , 4 hour start load dose . All ultrasound power doppler examination carry investigator , use Voluson 730 machine ( GE Healthcare Austria GmbH , Seoul , Korea ) . Sample size calculation do use Stats Direct statistical software version 2.7.2 MS Windows , StatsDirect Ltd. , Cheshire , UK .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Obstetric Labor , Premature</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<criteria>imminent preterm labour ( , &gt; 4cm dilate , cervical effacement &gt; 60 % ) . &lt; 32 week gestational age . patient exclude study gestational age &gt; 32 week intrauterine fetal death multiple gestation fetal malformation palliative care need placental abruption Chorioamnionitis preecplamsia , diabetes suspected fetal compromise diagnose ultrasound CTG require delivery , indication caesarean section fetal growth restriction Also contraindication use Nifedipine e.g maternal cardiac disease , allergy Nifedipine , hypotension , hepatic dysfunction Contraindications To MgSo4 use Myasthenia Gravis , progressive muscle weakness , allergy MgSo4 , severe renal impairment &amp; heart block .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Neuroprotection</keyword>
	<keyword>calcium channel blocker</keyword>
	<keyword>magnesium sulhate</keyword>
	<keyword>Middle cerebral artery doppler</keyword>
</DOC>